KK
PHAT icon

KLP Kapitalforvaltning’s Phathom Pharmaceuticals PHAT Stock Holding History

KLP Kapitalforvaltning’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Hold
14,000
– – ﹤0.01% 1989
2026
Q1 		$156K Hold
14,000
– – ﹤0.01% 1913
2025
Q4 		$232K Buy
+14,000
New +$200K ﹤0.01% 1784
2025
Q2 		– Sell
-9,100
Closed -$57.1K – 2250
2025
Q1 		$57.1K Hold
9,100
– – ﹤0.01% 2177
2024
Q4 		$73.9K Buy
+9,100
New +$113K ﹤0.01% 2178

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

KLP Kapitalforvaltning's PHAT Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Phathom Pharmaceuticals (PHAT) position steady in Q2 2026 at 14,000 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

KLP Kapitalforvaltning first reported a position in PHAT in Q4 2024 and has held it in 5 quarters since. The position peaked at $232K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • KLP Kapitalforvaltning held 14,000 shares of Phathom Pharmaceuticals worth $152K as of Q2 2026.
  • KLP Kapitalforvaltning left its Phathom Pharmaceuticals share count unchanged in Q2 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1989 holding.
  • KLP Kapitalforvaltning first reported a position in Phathom Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • KLP Kapitalforvaltning's Phathom Pharmaceuticals position peaked at $232K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.